16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To investigate the global molecular effects of tocilizumab (TCZ) in comparison with methotrexate (MTX) treatment in synovial biopsy tissue obtained from patients with previously untreated rheumatoid arthritis (RA) before therapy (T0) and 12 weeks after the initiation of therapy (T12), and to compare the results with previous gene expression data obtained in synovial biopsy tissue from adalimumab (ADA)- and rituximab (RTX)-treated patients with RA.

          Related collections

          Author and article information

          Journal
          Arthritis & rheumatology (Hoboken, N.J.)
          2326-5205
          2326-5191
          Jan 2014
          : 66
          : 1
          Affiliations
          [1 ] Université Catholique de Louvain, Brussels, Belgium.
          Article
          10.1002/art.38202
          24449571
          2cad8948-4aae-4c0b-a18e-cd8eb0443c39
          Copyright © 2014 by the American College of Rheumatology.
          History

          Comments

          Comment on this article